Reducing the prime cardiopulmonary bypass volume during paediatric cardiac surgery.

blood transfusion cardiac surgical procedures congenital heart defects mediastinitis paediatrics perfusionists

Journal

Perfusion
ISSN: 1477-111X
Titre abrégé: Perfusion
Pays: England
ID NLM: 8700166

Informations de publication

Date de publication:
01 Nov 2024
Historique:
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 1 11 2024
Statut: aheadofprint

Résumé

Despite technological advances, the use of homologous blood to prime the cardiopulmonary bypass (CPB) circuits of infants under 10 kg remains common. However, such rapid massive transfusion may increase post-CPB morbidity. We retrospectively included consecutive patients weighing 2.3-10 kg who underwent cardiac surgery under CPB. Patients were divided into two groups based on their priming volumes: low priming volume (LPV) (below the median volume) or high priming volume (HPV) (the median volume or above). The study included 208 patients, of whom 104 had priming volumes below the median [37.9 (28.4-51.7) mL/kg] and 104 had at least the median volume. We recorded positive correlations between the priming volume, on the one hand, and the peak creatinine and CRP levels within 5 days postoperatively, the duration of intensive care unit (ICU) stay, and the mechanical ventilation time, on the other. A relationship was also observed between a higher median priming volume and the need for renal replacement therapy in the ICU and mediastinitis. Although the differences in priming volume between the twogroups were small, they significantly influenced the postoperative complications. Perfusionists should seek to limit the priming volume to reduce the post-CPB inflammatory response, the duration of ICU stay, and possibly the risk of mediastinitis.

Identifiants

pubmed: 39484829
doi: 10.1177/02676591241296319
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2676591241296319

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Laurent Mathieu (L)

Department of Pediatric and Congenital Cardiovascular surgery, Haut-Lévêque Hospital, Surgical Centre, Bordeaux University Hospital, Pessac, France.

César Brunetti (C)

Department of Pediatric and Congenital Cardiovascular surgery, Timone Hopital, Aix Marseille University Hospital, Marseille, France.

Jean Detchepare (J)

Department of Pediatric and Congenital Cardiovascular surgery, Haut-Lévêque Hospital, Surgical Centre, Bordeaux University Hospital, Pessac, France.

Maude Flambard (M)

Department of Pediatric and Congenital Cardiovascular surgery, Haut-Lévêque Hospital, Surgical Centre, Bordeaux University Hospital, Pessac, France.

Christine Germain (C)

Research and Innovation Unit in Healthcare and Humanities (URISH), Bordeaux- University Hospital, Bordeaux, France.

Elise Langouet (E)

Department of Cardiovascular Anesthesia and Critical Care, CHU Bordeaux, Bordeaux, France.

Nadir Tafer (N)

Department of Cardiovascular Anesthesia and Critical Care, CHU Bordeaux, Bordeaux, France.

François Roubertie (F)

Department of Pediatric and Congenital Cardiovascular surgery, Haut-Lévêque Hospital, Surgical Centre, Bordeaux University Hospital, Pessac, France.
IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac, France.

Alexandre Ouattara (A)

Department of Cardiovascular Anesthesia and Critical Care, CHU Bordeaux, Bordeaux, France.
Univ. Bordeaux, INSERM, U1034, Biology of Cardiovascular Diseases, Pessac, France.

Classifications MeSH